Zydus Lifesciences Buyback 2024 Latest News Today

February 10, 2024 2:54:00 PM

Zydus Life buyback 2024, Zydus Lifesciences buyback 2024: Zydus Lifesciences, formerly known as Cadila Healthcare, has approved a buyback of equity shares at its board meeting held this Friday.

February 13, 2024 2:17:00 PM

Zydus Lifesciences formed strong bullish candlestick ... Zydus Life Q3 results: The Board approved buy-back of upto Rs. 6000 million at Rs. 1005 per equity share (25% premium to closing share ...

April 9, 2024 11:35:00 AM

AbbVie, Merck and Allergan sued Zydus Pharmaceuticals on April 5 in New Jersey District Court over patent infringement claims. The court action, asserting four patents related to the plaintiffs ...

May 2, 2024 3:30:00 AM

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

April 22, 2024 9:32:00 AM

Zydus Lifesciences has launched a generic medication to treat overactive bladder in the US market. The drug, Mirabegron, is indicated for symptoms such as urge urinary incontinence and urgency. Zydus ...

April 22, 2024 8:43:00 PM

Zydus Lifesciences on Monday said it has launched a generic medication to treat overactive bladder in the US market. The company has launched Mirabegron extended-release tablets in strength of 25 ...

April 22, 2024 11:54:00 AM

AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as �Zydus�) announces the launch of ...

April 23, 2024 6:14:00 PM

Zydus Lifesciences announced on Monday that it has introduced a generic drug to treat overactive bladder in the United States. Zydus Lifesciences announced in a regulatory filing that Mirabegron ...

May 3, 2024 3:30:00 AM

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

April 10, 2024 1:43:00 AM

Zydus Lifesciences on Monday said it has launched a generic medication to treat overactive bladder in the US market. The company has launched Mirabegron extended-release tablets in strength of 25 ...